CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Goodwill, Foreign Currency Translation Gain (Loss)
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) reported Goodwill, Foreign Currency Translation Gain (Loss) of -$25.39 million for the 6-month period ending 2026-06-27, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement › Other Income
us-gaap:GoodwillForeignCurrencyTranslationGainLoss · last filed 2026-08-05
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. goodwill, foreign currency translation gain (loss) for the quarter ending 2026-06-27 was -$6.84M, a 110.88% decline year-over-year.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. goodwill, foreign currency translation gain (loss) for the quarter ending 2026-03-28 was -$18.55M, a 160.25% decline year-over-year.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. goodwill, foreign currency translation gain (loss) for the quarter ending 2025-12-27 was $6.97M.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. goodwill, foreign currency translation gain (loss) for the quarter ending 2025-09-27 was -$13.98M, a 131.15% decline year-over-year.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. goodwill, foreign currency translation gain (loss) for fiscal 2025 was $86.64M.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. goodwill, foreign currency translation gain (loss) for fiscal 2024 was -$51.11M, a 243.32% decline from fiscal 2023.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. goodwill, foreign currency translation gain (loss) for fiscal 2023 was $35.66M.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. goodwill, foreign currency translation gain (loss) for fiscal 2022 was -$73.97M.
| Period end | Goodwill, Foreign Currency Translation Gain (Loss) 3 month | Goodwill, Foreign Currency Translation Gain (Loss) 6 month | Goodwill, Foreign Currency Translation Gain (Loss) 9 month | Goodwill, Foreign Currency Translation Gain (Loss) 12 month |
|---|---|---|---|---|
| 2026-06-27 | -$6.84M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$25.39M 10-Q · filed 2026-08-05 | -$18.42M derived: sum of 3 quarters · filed 2026-08-05 | -$32.41M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-28 | -$18.55M 10-Q · filed 2026-05-07 | -$11.58M derived: sum of 2 quarters · filed 2026-05-07 | -$25.57M derived: sum of 3 quarters · filed 2026-05-07 | $37.30M derived: sum of 4 quarters · filed 2026-05-07 |
| 2025-12-27 | $6.97M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-18 | -$7.01M derived: sum of 2 quarters · filed 2026-02-18 | $55.85M derived: sum of 3 quarters · filed 2026-02-18 | $86.64M 10-K · filed 2026-02-18 |
| 2025-09-27 | -$13.98M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $48.88M derived: sum of 2 quarters · filed 2025-11-05 | $79.67M 10-Q · filed 2025-11-05 | $16.69M derived: sum of 4 quarters · filed 2026-02-18 |
| 2025-06-28 | $62.86M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $93.66M 10-Q · filed 2025-08-06 | $30.67M derived: sum of 3 quarters · filed 2026-02-18 | $75.57M derived: sum of 4 quarters · filed 2026-02-18 |
| 2025-03-29 | $30.79M 10-Q · filed 2025-05-07 | -$32.19M derived: sum of 2 quarters · filed 2026-02-18 | $12.71M derived: sum of 3 quarters · filed 2026-02-18 | $4.98M derived: sum of 4 quarters · filed 2026-02-18 |
| 2024-12-28 | -$62.98M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-18 | -$18.09M derived: sum of 2 quarters · filed 2026-02-18 | -$25.81M derived: sum of 3 quarters · filed 2026-02-18 | -$51.11M 10-K · filed 2026-02-18 |
| 2024-09-28 | $44.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $37.17M derived: sum of 2 quarters · filed 2024-11-06 | $11.87M 10-Q · filed 2024-11-06 | $49.97M derived: sum of 4 quarters · filed 2025-02-19 |
| 2024-06-29 | -$7.73M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | -$33.03M 10-Q · filed 2024-08-07 | $5.07M derived: sum of 3 quarters · filed 2025-02-19 | -$26.92M derived: sum of 4 quarters · filed 2025-02-19 |
| 2024-03-30 | -$25.30M 10-Q · filed 2024-05-09 | $12.79M derived: sum of 2 quarters · filed 2025-02-19 | -$19.20M derived: sum of 3 quarters · filed 2025-02-19 | -$4.23M derived: sum of 4 quarters · filed 2025-02-19 |
| 2023-12-30 | $38.09M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-19 | $6.10M derived: sum of 2 quarters · filed 2025-02-19 | $21.07M derived: sum of 3 quarters · filed 2025-02-19 | $35.66M 10-K · filed 2025-02-19 |
| 2023-09-30 | -$31.99M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | -$17.02M derived: sum of 2 quarters · filed 2023-11-08 | -$2.43M 10-Q · filed 2023-11-08 | $74.64M derived: sum of 4 quarters · filed 2024-02-14 |
| 2023-07-01 | $14.97M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $29.56M 10-Q · filed 2023-08-09 | $106.63M derived: sum of 3 quarters · filed 2024-02-14 | $22.95M derived: sum of 4 quarters · filed 2024-02-14 |
| 2023-04-01 | $14.60M 10-Q · filed 2023-05-11 | $91.66M derived: sum of 2 quarters · filed 2024-02-14 | $7.98M derived: sum of 3 quarters · filed 2024-02-14 | -$44.08M derived: sum of 4 quarters · filed 2024-02-14 |
| 2022-12-31 | $77.07M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-14 | -$6.62M derived: sum of 2 quarters · filed 2024-02-14 | -$58.67M derived: sum of 3 quarters · filed 2024-02-14 | -$73.97M 10-K · filed 2024-02-14 |
| 2022-09-24 | -$83.68M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | -$135.74M derived: sum of 2 quarters · filed 2022-11-02 | -$151.04M 10-Q · filed 2022-11-02 | -$177.27M derived: sum of 4 quarters · filed 2023-02-22 |
| 2022-06-25 | -$52.06M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03 | -$67.36M 10-Q · filed 2022-08-03 | -$93.59M derived: sum of 3 quarters · filed 2023-02-22 | -$112.96M derived: sum of 4 quarters · filed 2023-02-22 |
| 2022-03-26 | -$15.29M 10-Q · filed 2022-05-04 | -$41.53M derived: sum of 2 quarters · filed 2023-02-22 | -$60.90M derived: sum of 3 quarters · filed 2023-02-22 | -$48.46M derived: sum of 4 quarters · filed 2023-02-22 |
| 2021-12-25 | -$26.24M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22 | -$45.61M derived: sum of 2 quarters · filed 2023-02-22 | -$33.16M derived: sum of 3 quarters · filed 2023-02-22 | -$40.31M 10-K · filed 2023-02-22 |
| 2021-09-25 | -$19.37M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | -$6.93M derived: sum of 2 quarters · filed 2021-11-03 | -$14.07M 10-Q · filed 2021-11-03 | $17.52M derived: sum of 4 quarters · filed 2022-02-16 |
| 2021-06-26 | $12.44M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04 | $5.29M 10-Q · filed 2021-08-04 | $36.89M derived: sum of 3 quarters · filed 2022-02-16 | $58.27M derived: sum of 4 quarters · filed 2022-02-16 |
| 2021-03-27 | -$7.15M 10-Q · filed 2021-05-04 | $24.45M derived: sum of 2 quarters · filed 2022-02-16 | $45.83M derived: sum of 3 quarters · filed 2022-02-16 | $49.71M derived: sum of 4 quarters · filed 2022-02-16 |
| 2020-12-26 | $31.60M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-16 | $52.98M derived: sum of 2 quarters · filed 2022-02-16 | $56.86M derived: sum of 3 quarters · filed 2022-02-16 | $39.58M 10-K · filed 2022-02-16 |
| 2020-09-26 | $21.38M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29 | $25.26M derived: sum of 2 quarters · filed 2020-10-29 | $7.98M 10-Q · filed 2020-10-29 | $26.66M derived: sum of 4 quarters · filed 2021-02-17 |
| 2020-06-27 | $3.88M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | -$13.40M 10-Q · filed 2020-08-05 | $5.28M derived: sum of 3 quarters · filed 2021-02-17 | -$17.82M derived: sum of 4 quarters · filed 2021-02-17 |
| 2020-03-28 | -$17.28M 10-Q · filed 2020-05-07 | $1.40M derived: sum of 2 quarters · filed 2021-02-17 | -$21.70M derived: sum of 3 quarters · filed 2021-02-17 | -$15.95M derived: sum of 4 quarters · filed 2021-02-17 |
| 2019-12-28 | $18.68M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-17 | -$4.42M derived: sum of 2 quarters · filed 2021-02-17 | $1.34M derived: sum of 3 quarters · filed 2021-02-17 | $52.00K 10-K · filed 2021-02-17 |
| 2019-09-28 | -$23.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | -$17.34M derived: sum of 2 quarters · filed 2019-11-06 | -$18.63M 10-Q · filed 2019-11-06 | -$25.19M derived: sum of 4 quarters · filed 2020-02-11 |
| 2019-06-29 | $5.76M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-31 | $4.47M 10-Q · filed 2019-07-31 | -$2.09M derived: sum of 3 quarters · filed 2020-02-11 | -$6.71M derived: sum of 4 quarters · filed 2020-02-11 |
| 2019-03-30 | -$1.28M 10-Q · filed 2019-05-07 | -$7.85M derived: sum of 2 quarters · filed 2020-02-11 | -$12.47M derived: sum of 3 quarters · filed 2020-02-11 | -$34.70M derived: sum of 4 quarters · filed 2020-02-11 |
| 2018-12-29 | -$6.56M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-11 | -$11.18M derived: sum of 2 quarters · filed 2020-02-11 | -$33.41M derived: sum of 3 quarters · filed 2020-02-11 | -$20.55M 10-K · filed 2020-02-11 |
| 2018-09-29 | -$4.62M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | -$26.85M derived: sum of 2 quarters · filed 2018-11-07 | -$13.98M 10-Q · filed 2018-11-07 | -$8.74M derived: sum of 4 quarters · filed 2019-02-13 |
| 2018-06-30 | -$22.23M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | -$9.37M 10-Q · filed 2018-08-08 | -$4.13M derived: sum of 3 quarters · filed 2019-02-13 | $7.14M derived: sum of 4 quarters · filed 2019-02-13 |
| 2018-03-31 | $12.87M 10-Q · filed 2018-05-10 | $18.11M derived: sum of 2 quarters · filed 2019-02-13 | $29.37M derived: sum of 3 quarters · filed 2019-02-13 | $49.52M derived: sum of 4 quarters · filed 2019-02-13 |
| 2017-12-30 | $5.24M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-13 | $16.50M derived: sum of 2 quarters · filed 2019-02-13 | $36.66M derived: sum of 3 quarters · filed 2019-02-13 | $41.45M 10-K · filed 2019-02-13 |
| 2017-09-30 | $11.26M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $31.42M derived: sum of 2 quarters · filed 2017-11-09 | $36.21M 10-Q · filed 2017-11-09 | |
| 2017-07-01 | $20.16M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | $24.95M 10-Q · filed 2017-08-09 | ||
| 2017-04-01 | $4.79M 10-Q · filed 2017-05-10 | |||
| 2016-09-24 | -$16.09M 10-Q · filed 2016-11-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |